Fiberglass Found in IV Bags Triggers Nationwide Recall

A medical company called Baxter International is recalling two batches of a common IV fluid after fiberglass particles were found inside the solution. The product is a saltwater mixture known as 0.9% Sodium Chloride Injection, which hospitals use to keep patients hydrated and to help run kidney dialysis machines. The U.S. Food and Drug Administration, known as the FDA, announced the recall after the contamination was discovered. The affected bags were shipped to 14 states between July 31 and August 3.

Baxter said the two recalled batches — identified by lot numbers Y495523 and Y495523A — both have an expiration date of October 31, 2027. The bags come in 500 ml flexible plastic containers called VIAFLEX containers. Healthcare providers and distributors in 14 states received the affected products. Those states include Florida, Illinois, Indiana, Louisiana, Maryland, Missouri, North Carolina, New Jersey, Nevada, New York, Ohio, South Carolina, Texas, and Virginia.

Fiberglass contamination in medicine-making is not common, but it can happen. Factories that make medicines use many safety steps — like filtration systems and equipment inspections — to stop foreign materials from getting into their products. However, damaged equipment or faulty packaging can sometimes allow particles like fiberglass to slip through. When that happens, the company is required to recall the product to protect patients.

This recall is especially serious because the fluid goes directly into a patient's bloodstream through an IV line. That makes contamination far more dangerous than it would be in a pill or liquid medicine you swallow. When harmful particles enter the blood, the body cannot filter them out as easily. Even a small amount of fiberglass in the blood can cause serious health problems.

According to Baxter's recall notice, fiberglass particles in the bloodstream could block blood vessels and cause dangerous clotting. If blood flow is cut off from important organs, the results can be life-threatening. In the worst cases, this could lead to a pulmonary embolism — a dangerous blockage in the lungs — permanent organ damage, or even death. The particles could also irritate veins, cause swelling, make existing infections worse, or trigger allergic reactions.

As of August 25, Baxter said it had not received any reports of patients being harmed by the recalled product. The company has been reaching out to customers by email with instructions on how to identify and return the affected bags. Hospitals and distributors have been told to stop using the product right away and follow their facility's return procedures. Anyone who thinks they may have had a reaction to the product is urged to contact a doctor.